Marco Lucarelli

Pubblicazioni

Titolo Pubblicato in Anno
Early routine biomarkers of SARS-CoV-2 morbidity and mortality: outcomes from an emergency section DIAGNOSTICS 2022
Safety of multiple vaccinations and durability of vaccine‐induced antibodies in an Italian military cohort 5 years after immunization BIOMEDICINES 2022
Alcohol and head and neck cancer: updates on the role of oxidative stress, genetic, epigenetics, oral microbiota, antioxidants, and alkylating agents ANTIOXIDANTS 2022
Urinary ethyl glucuronide for the assessment of alcohol consumption during pregnancy: comparison between biochemical data and screening questionnaires CURRENT MEDICINAL CHEMISTRY 2022
Clinical outcomes of a large cohort of individuals with the F508del/5T;TG12 CFTR genotype JOURNAL OF CYSTIC FIBROSIS 2022
Downregulation of epithelial sodium channel (ENaC) activity in cystic fibrosis cells by epigenetic targeting CELLULAR AND MOLECULAR LIFE SCIENCES 2022
Printed Electrochemical Strip for the Detection of miRNA-29a: A Possible Biomarker Related to Alzheimer’s Disease ANALYTICAL CHEMISTRY 2022
NGF and BDNF in Pediatrics Syndromes NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS 2022
Antioxidant intervention to improve cognition in the aging brain: the example of hydroxytyrosol and resveratrol INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022
Transient plasma cell dyscrasia in COVID-19 patients linked to IL-6 triggering. MICROBES AND INFECTION 2021
Quantitative evaluation of CFTR pre-mRNA splicing dependent on the (TG)mTn poly-variant tract DIAGNOSTICS 2021
DNA methylation patterns correlate with the expression of SCNN1A, SCNN1B, and SCNN1G (Epithelial sodium channel, ENaC) genes INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2021
Alcohol drinking, apolipoprotein polymorphisms and the risk of cardiovascular diseases CURRENT NEUROVASCULAR RESEARCH 2021
A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS/CFSPID) in six Italian centres JOURNAL OF CYSTIC FIBROSIS 2021
Mediterranean diet, brain and muscle: olive polyphenols and resveratrol protection in neurodegenerative and neuromuscular disorders CURRENT MEDICINAL CHEMISTRY 2021
Transgenerational abnormalities induced by paternal preconceptual alcohol drinking. Findings from humans and animal models CURRENT NEUROPHARMACOLOGY 2021
Outcomes of early repeat sweat testing in infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/CF screen-positive, inconclusive diagnosis PEDIATRIC PULMONOLOGY 2021
Theratyping cystic fibrosis in vitro in ALI culture and organoid models generated from patient-derived nasal epithelial conditionally reprogrammed stem cells EUROPEAN RESPIRATORY JOURNAL 2021
Cpg and non-Cpg presenilin1 methylation pattern in course of neurodevelopment and neurodegeneration is associated with gene expression in human and murine brain EPIGENETICS 2020
The complex interplay between DNA methylation and miRNAs in gene expression regulation BIOCHIMIE 2020

ERC

  • LS1_3
  • LS2_2
  • LS2_3
  • LS2_4
  • LS2_14
  • LS3_12
  • LS3_13

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

- regulation of DNA methylation and demethylation processes in eukaryotic cells;

- DNA methylation, modulation of gene expression and cell differentiation;

- molecular mechanisms of the gene therapy by small fragment homologous replacement (SFHR);

- molecular genetics of cystic fibrosis and of CFTR-related disorders and study of the genotype/phenotype relationship in this diseases;

- theratyping of cystic fibrosis;

- functional characterization of CFTR (cystic fibrosis transmembrane conductance regulator) and ENaC (epithelial sodium channel) genes in physiologic and pathologic conditions;

- molecular diagnostic methodologies and pathogenetic mechanisms underlying cystic fibrosis, CFTR-related disorders, atherosclerosis, alcohol addiction and neurological disorders;

- setup and automation of mutational search methodologies.

Keywords

cystic fibrosis
DNA methylation
Personalized therapy
gene editing

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma